Navigation Links


ZIO at medicine technology

ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

NEW YORK--(BUSINESS WIRE)--Jul 6, 2007 - ZIOPHARM Oncology, Inc.(NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, ChiefExecutive Officer, will present at the C.E. Unterberg, TowbinEmerging Growth Opportunities Conference on Thursday, July 12, 2007at 2:30 p.m. ET at the Mandarin Oriental Hotel, New York. Dr. Lewiswill provide an overview of the Company and an update on itsclinical deve...

Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology

LUGANO, Switzerland--(BUSINESS WIRE)--Jul 9, 2007 - ZIOPHARMOncology, Inc. (NASDAQ: ZIOP) announces that positive interim datafrom an ongoing phase II trial of ZIO-201 (isophosphoramide mustard- IPM) to treat advanced sarcoma patients was presented at theEuropean Society of Medical Oncology (ESMO) meeting held July 5-8,2007 in Lugano, Switzerland. The abstract entitled, "Phase-I/IIStudy of...

ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop

KOS, Greece--(BUSINESS WIRE)--Jun 28, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ZIOP), announced today the presentation of twoposters at the XIth Annual International Myeloma Workshop beingheld in Kos, Greece from June 25-28th, 2007. The meeting highlightsimportant advances made in the biology and treatment of multiplemyeloma. ZIOPHARM is presenting darinaparsin (ZIO-101) geneexpression profil...

ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR

LOS ANGELES--(BUSINESS WIRE)--Apr 17, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ZIOP) announced today the presentation of preclinicaldata strongly supportive of the development of an oral form ofZIO-101. Specifically, ZIO-101 demonstrates very highbioavailability when administered orally; in addition it evidencesanti-angiogenic activity that is particularly well suited to oraladministration. T...

ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR

LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ZIOP) announced today the presentation of preclinicaldata for an orally active form of ZIO-201 (isophosphoramide mustard- IPM) at the American Association of Cancer Research meeting beingheld in Los Angeles. Data presented demonstrated oral availabilityof ZIO-201 and activity in a variety of cancer models, including...

ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR

LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ZIOP) presented preclinical data yesterday onindibulin (ZIO-301) at the American Association of Cancer Research(AACR) meeting in Los Angeles. These data demonstrate thatindibulin has distinct biologic and molecular properties from othertubulin binding agents and strongly suggest a very differenttoxicity profile, pa...

ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH

PUNTA DEL ESTE, Uruguay--(BUSINESS WIRE)--Mar 23, 2007 - ZIOPHARMOncology, Inc. (NASDAQ: ZIOP) announced today the presentation ofdata on ZIO-201 at the XXXI World Congress of the InternationalSociety of Hematology (ISH) meeting being held in Punta del Este,Uruguay. ZIO-201 is a proprietary form of the therapeutic activemetabolite of ifosfamide (IFOS), a drug that is widely used in thetreat...
Other TagsDysfunctionPrisonerOverdoseiGATEiGATE
(Date:8/28/2008)... , Quicker microwave meals that use less energy m...hes and, according to the material scientists resp...c waste remediation. , , "Currently, food heate...se the dishes are transparent to microwaves," says...y mineralogy, College of Agricultural Sciences at ...
(Date:8/28/2008)... , Researchers at The University of Nottingham ha...to develop a new drug that could ease the sufferin...ts who are unable to take beta-blockers. , In th... and most are able to have their symptoms effectiv...drugs which stop adrenaline from making the heart ...
(Date:8/28/2008)... , BIRMINGHAM, Ala. -- Intravenous magnesium su... the risk for handicapping cerebral palsy in half,...a at Birmingham (UAB) obstetrician Dwight Rouse, M...w England Journal of Medicine. , Cerebral palsy...ting control of movement and posture and limiting ...
(Date:8/27/2008)... ,, DALLAS Aug. 28, 2008 Researchers at UT...ce that the brain must create new nerve cells for ...ssion-like behavior. , In addition, the research...e same biochemical pathway to exert their effects.... mechanisms of antidepressants and provide a new d...
Breaking Biology News(10 mins):Ceramic material revs up microwaving 2New beta-blocker to offer hope to heart and lung sufferers 2Common treatment to delay labor decreases preterm infants' risk for cerebral palsy 2Common treatment to delay labor decreases preterm infants' risk for cerebral palsy 3Antidepressants need new nerve cells to be effective, UT Southwestern researchers find 2Why do astronauts suffer from space sickness 3F 20003 1Why do astronauts suffer from space sickness 3F 20003 2Lilly Announces Changes in Key Leadership Roles 20000 1Lilly Announces Changes in Key Leadership Roles 20000 2Lilly Announces Changes in Key Leadership Roles 20000 3Lilly Announces Changes in Key Leadership Roles 20000 4Lilly Announces Changes in Key Leadership Roles 20000 5VA Secretary Appoints Panel of National Suicide Experts 19997 1VA Secretary Appoints Panel of National Suicide Experts 19997 2 C O R R E C T I O N Rosetta Genomics Ltd 5557 1 C O R R E C T I O N Rosetta Genomics Ltd 5557 2 C O R R E C T I O N Rosetta Genomics Ltd 5557 3 C O R R E C T I O N Rosetta Genomics Ltd 5557 4 C O R R E C T I O N Rosetta Genomics Ltd 5557 5 C O R R E C T I O N Rosetta Genomics Ltd 5557 6 C O R R E C T I O N Rosetta Genomics Ltd 5557 7 C O R R E C T I O N Rosetta Genomics Ltd 5557 8 C O R R E C T I O N Rosetta Genomics Ltd 5557 9 C O R R E C T I O N Rosetta Genomics Ltd 5557 10 C O R R E C T I O N Rosetta Genomics Ltd 5557 11 C O R R E C T I O N Rosetta Genomics Ltd 5557 12 C O R R E C T I O N Rosetta Genomics Ltd 5557 13 C O R R E C T I O N Rosetta Genomics Ltd 5557 14 C O R R E C T I O N Rosetta Genomics Ltd 5557 15 C O R R E C T I O N Rosetta Genomics Ltd 5557 16 C O R R E C T I O N Rosetta Genomics Ltd 5557 17 C O R R E C T I O N Rosetta Genomics Ltd 5557 18 C O R R E C T I O N Rosetta Genomics Ltd 5557 19 C O R R E C T I O N Rosetta Genomics Ltd 5557 20
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
Other Contentsorbitalorbitalorbitalorbitalorchiectomyorchitisorgasmorgasmorthopaedicsorganicorganicorganicorganicorganicorganicorganicorganicosmolalityorificeorifice